Diabetes and SARS-CoV-2 Infection: The Potential Role of Antidiabetic Therapy in the Evolution of COVID-19
Diabetes mellitus represents one of the most frequent comorbidities among patients with COVID-19, constituting a risk factor for a more severe prognosis than that of non-diabetic patients. However, the pathophysiological mechanism underlying this unfavorable outcome is still not completely clear. Th...
Main Authors: | Biagio Pinchera, Nicola Schiano Moriello, Antonio Riccardo Buonomo, Isabella Di Filippo, Anastasia Tanzillo, Giorgio Buzzo, Riccardo Villari, Ivan Gentile, Federico II COVID Team |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/11/1/145 |
Similar Items
-
The mTOR Signaling Pathway in Multiple Sclerosis; from Animal Models to Human Data
by: Aigli G. Vakrakou, et al.
Published: (2022-07-01) -
Update on the Management of Surgical Site Infections
by: Biagio Pinchera, et al.
Published: (2022-11-01) -
Effect of Sirolimus/Metformin Co-Treatment on Hyperglycemia and Cellular Respiration in BALB/c Mice
by: Alia Albawardi, et al.
Published: (2023-01-01) -
Immunomodulatory and Antiaging Mechanisms of Resveratrol, Rapamycin, and Metformin: Focus on mTOR and AMPK Signaling Networks
by: Vincenzo Sorrenti, et al.
Published: (2022-07-01) -
Metformin as a Treatment Strategy for Sjögren’s Syndrome
by: Joa Kim, et al.
Published: (2021-07-01)